Abstract-Aim of our study was to ascertain, prospectively, whether serum uric acid is a suitable predictor of preeclampsia and/or the delivery of small-for-gestational-age infants in women with gestational hypertension. We screened 206 primiparas, with a singleton pregnancy, referred for recent onset of hypertension. At presentation, we measured serum uric acid, creatinine, blood glucose, hemoglobin and platelet level, and 24-hour proteinuria, as well as office and 24-hour blood pressures. We followed the women until 1 month after delivery and recorded pregnancy outcome. After logistic regression analysis, uric acid resulted a significant predictor of preeclampsia, with an unadjusted odds ratio of 9.1 (95% CI: 4.8 to 17.4; PϽ0.001); after adjustment for age, gestation week, hemoglobin and platelet levels, serum creatinine, office and 24-hour average systolic and diastolic blood pressures, it was 7.1 (95% CI: 3.2 to 15.7; PϽ0.001). Regarding the association between maternal serum uric acid and the chance of giving birth to a small-for-gestational-age infant, the unadjusted odds ratio was 1.7 (95% CI: 1.4 to 2.2; PϽ0.001), and it was 1.6 (95% CI: 1.1 to 2.4; Pϭ0.02) after adjustment. Receiver operating characteristic analysis showed that serum uric acid, at a 309-mol/L cutoff, predicted the development of preeclampsia (area under the curve: 0.955), with 87.7% sensitivity and 93.3% specificity, and the delivery of small-for-gestational-age infants (area under the curve: 0.784) with 83.7% sensitivity and 71.7% specificity.
H ypertensive disorders complicate Ϸ2% to 10% of all pregnancies. 1,2 Among these, preeclampsia remains one of the largest single causes of maternal and fetal mortality and morbidity, whereas uncomplicated gestational hypertension carries a far better prognosis. Clinical prediction of preeclampsia may facilitate initiation of timely management to avert mortality and morbidity in the mother and infant. Raised serum uric acid (UA) is one of the characteristic findings in preeclampsia. In clinical practice, serum UA determination is considered to be a part of the workup in women with preeclampsia to monitor disease severity and aid management of these women. The association between raised serum UA and preeclamptic pregnancies was first reported almost a century ago. 3 Reduced UA clearance secondary to reduced glomerular filtration rate, increased reabsorption, and decreased secretion may be at the origin of elevated serum levels in women with preeclampsia. 4, 5 Several studies have reported a positive correlation between elevated maternal serum UA and adverse maternal and fetal outcomes. 6 -10 A number of studies [11] [12] [13] [14] [15] have evaluated several tests and parameters, including UA, during the first or second trimester of pregnancy, as potential predictors of preeclampsia, with mixed results, and generally with unsatisfactory sensitivity and/or specificity. In this study, we have chosen to restrict our analysis to pregnant women referred to our unit for suspected hypertension to evaluate the prognostic value of serum UA for the subsequent development of preeclampsia and for giving birth to a small-for-gestational-age (SGA) infant, thus allowing us to identify the subgroup of hypertensive women at greater risk, necessitating of closer monitoring and surveillance.
Patients and Methods
Between July 2008 and July 2010, after obtaining their consent, we screened 206 nulliparous women submitted to our unit for suspected hypertension during pregnancy. Inclusion criteria were age Ͼ18 years, singleton pregnancy beyond the 20th week, blood pressure (BP) Ͼ140 mm Hg systolic or 90 mm Hg diastolic, and 24-hour proteinuria Ͻ300 mg. Known heart disease, nephropathy, or hypertension preceding pregnancy were reasons for exclusion from the study.
None of the subjects were treated with antihypertensive drugs on entry. As the patients entered the study, BP was obtained on 2 separate occasions, Ն6 hours apart, in a quiet environment with the subject seated. A physician on the hospital staff measured BP with a standard mercury sphygmomanometer. In our institution, all of the mercury sphygmomanometers are calibrated every 3 months against an electronic pressure generator. Diastolic BP was taken at Korotkoff phase 5, which has been shown to correspond more closely with intra-arterial measurement and be less dependent on the examiner's skill than Korotkoff phase 4. 16 Three measurements were taken, 5 minutes apart, and the average was recorded: the mean of the averages recorded on the 2 occasions was considered the actual BP. BP values Ն140 mm Hg systolic or 90 mm Hg diastolic were considered abnormal and used for diagnosis of hypertension. Also, after an overnight fast, blood samples were taken for routine tests, including serum creatinine, UA, blood glucose, and a full blood cell count, and a 24-hour collection was started for the measurement of proteinuria. First-trimester (determined between the ninth and 12th weeks of gestation) serum UA was taken from the woman's clinical record and was measured at the same laboratory at our hospital.
Within 4 days from the first visit, all of the women underwent ambulatory BP monitoring. An oscillometric pressurometer (TM2430, A&D Company, Tokyo, Japan) was used to measure 24-hour BP. Device accuracy was checked in every session against a mercury sphygmomanometer, and a difference Ͼ5 mm Hg was reason for exclusion from the study.
BP was recorded at 15-minute intervals both during the day and night for 25 hours, starting between 9:00 and 11:00 AM. Cuffs of appropriate size were used, always applied to the left arm.
All of the BP recordings from the first hour of monitoring were removed from analysis because they might be influenced by an alarm reaction. All of the readings with a pulse pressure Ͻ20 mm Hg, a diastolic BP Ͼ140 mm Hg or Ͻ40 mm Hg, or a systolic BP Ͼ250 mm Hg or Ͻ60 mm Hg were automatically rejected. The quality of 24-hour BP monitoring was judged satisfactory when Ն70% of the readings passed the editing criteria and Ն1 recording per hour was obtained. Daytime was defined as 7:00 AM to 11:00 PM.
All of the women were followed up at our hospital until the end of pregnancy and regularly Յ1 month after delivery, unless their clinical conditions dictated otherwise. The outcome of pregnancy was recorded, and clinical parameters regarding the newborn (weight, Apgar score, and duration of hospital stay) were also recorded. Preeclampsia was defined as gestational hypertension and proteinuria Ͼ300 mg in a timed 24-hour sample. Transient gestational hypertension was defined as the presence of normal office BP Ͻ140 mm Hg systolic and Ͻ90 mm Hg diastolic) 4 weeks after delivery in untreated women who had hypertension without preeclampsia during the third trimester of pregnancy. For the purpose of BMI indicates body mass index; UA, uric acid; BP, blood pressure; ABPM, ambulatory blood pressure measurement; SGA, small for gestational age.
the present study, SGA infants were defined as those weighing less than the 10th centile, based on nationwide derived centile charts for singleton births. 17 All of the results are expressed as meanϮSD, unless otherwise indicated. Comparisons between groups were performed using the unpaired Student t test for continuous variables and the Fisher exact test for proportions. Strength of association of UA with the outcomes (development of preeclampsia and SGA) was assessed by binary logistic regression, unadjusted first, and after adjustment for age, gestation week, serum creatinine, hemoglobin and platelet levels, and both office and ambulatory BPs; association of serum UA and other variables with birth weight centiles was evaluated by a multiple linear regression model. Predictive accuracy of laboratory and BP parameters was assessed by calculating the areas under the receiver operating characteristic curves, which were compared according to the method of Hanley and McNeil 18 ; optimal cutoff values were chosen as the point on the receiver operating characteristic curve, closest to the top left corner. P values Յ0.05 were considered as significant. All of the calculations were performed using the SPSS 15.0 (SPSS Inc, Chicago, IL), and Medcalc 9.1 (Mariakerke, Belgium) software.
The study was approved by the hospital ethics committee. Because the study parameters were noninvasive and obtained as part of a routine clinical management, the committee did not require signed informed consent; however, verbal informed consent was obtained in all of the cases.
Results
Overall, 163 women completed the study; among those who did not, 20 were excluded because they did not meet the BP criteria on entry, 3 because of proteinuria Ͼ300 mg/24 hours, 7 because of incomplete clinical data, and 11 because of insufficient quality of the ambulatory BP monitoring recordings, and 2 withdrew their consent.
Seventy-three women (44.7%) developed preeclampsia, and 43 SGA infants (26.4%) were born. One stillbirth occurred. The average interval between time of study entry and preeclampsia diagnosis was 14.7Ϯ5.1 days.
Demographic, laboratory, perinatal, and BP parameters are shown in Table 1 . Women who developed preeclampsia tended to be younger and have higher levels of UA, hemoglobin, and creatinine; lower levels of platelets; a higher incidence of cesarean section and SGA infants; and both higher office and monitored BP. Table 2 shows the results of logistic regression analysis: the unadjusted odds ratio for UA associated with the development of preeclampsia was 9.1 (95% CI: 4.8 to 17.4; PϽ0.001), and after adjustment for age, gestation week, hemoglobin and platelet levels, serum creatinine, office systolic and diastolic BPs, and 24-hour average systolic and diastolic BPs, it was 7.1 (95% CI: 3.2 to 15.7; PϽ0.001). When the association between maternal serum UA and the chance of giving birth to an SGA infant was considered, the unadjusted odds ratio was lower (1.6; 95% CI: 1.1 to 2.4; PϽ0.001), and after adjusting for confounders it was 1.6 (95% CI: 1.1 to 2.3; Pϭ0.02). In this regression model, first-trimester UA was not significantly associated with either preeclampsia or SGA (Table 2) . Table 3 shows the results of multiple linear regression, with birth weight centile as the dependent variable: again, serum UA and monitored diastolic BP 24-hour average were the only variables significantly associated with birth weight centile. Hyperuricemic (UA Ͼ309 mol/L; nϭ9) women who did not develop preeclampsia had a higher incidence of SGA compared with normouricemic women (22.2% versus 4.9%; Pϭ0.05).
Receiver operating characteristic analysis (Table 4 ) showed that serum UA was an accurate predictor of preeclampsia in this population (areas under the receiver operating characteristic curve: 0.955; sensitivity: 87.7%; specificity: 93.3%; positive predictive value: 91.4%; negative predictive value: 9.6%, for a cutoff of 309 mol/L [5.2 mg/dL]), as well as serum UA increase from first trimester (areas under the receiver operating characteristic curve: 0.961; sensitivity: 90.4%; specificity: 97.8%; positive predictive value: 97.1%; negative predictive value: 7.4%, for a cutoff of 113 mol/L [1.9 mg/dL]); a combination of the above criteria (either UA level Ͼ309 mol/L or an increase Ͼ113 mol/L) yielded a sensitivity of 93.6% and a specificity of 91.8% (positive predictive value: 90.2%: negative predictive value: 5.2%). Dependent variables were preeclampsia and SGA; explanatory variables were as follows: age, gestation wk, serum creatinine, UA (current and first-trimester levels), hemoglobin and platelet levels, office and ambulatory systolic and diastolic BPs. UA indicates uric acid; BP, blood pressure; SGA, small for gestational age.
First-trimester UA was a poor predictor of preeclampsia, and it showed a sensitivity of Ϸ80% but unacceptably poor specificity for SGA prediction (Table 4) . Regarding BP parameters (Table 4) , monitored BP performed better than office BP and diastolic better than systolic BP for the prediction of both preeclampsia and SGA, although not as well as UA.
Discussion
In this sample of women with gestational hypertension, we have identified UA as a reliable predictor of preeclampsia. Although the literature reporting predictive indicators for preeclampsia is fairly extensive, evidence on the accuracy of various tests to predict preeclampsia in women with gestational hypertension is sparse and based mostly on retrospective analyses, rather than on cohort studies, such as the one we are reporting. Recently, several studies, 4,7,9,10,14 mostly retrospective, have shown an association between firsttrimester UA and the later development of preeclampsia and/or SGA. In our sample of patients (which included only women with suspected gestational hypertension), firsttrimester UA was not associated so strongly with adverse outcomes; actually, although a fairly sensitive marker for SGA (86.0% sensitivity), it lacked specificity. Conversely, when measured at the moment of initial hospital admission, at first diagnosis of pregnancy-induced hypertension, UA (and even better, its increase from first trimester) carries a much higher prognostic value, with a strong correlation to adverse maternal outcomes, as reported in 2 recent retrospective studies. 19, 20 However, retrospective, case-control studies are known to provide more "optimistic" results regarding the predictive capability of a model, with respect to cohort studies, 21 because of the fact that, in case-control studies, controls are generally on the healthy side of the disease spectrum, whereas cases generally display the most severe presentation of a given disease. In this respect, we believe our prospective study lends stronger support for a role of UA as a predictor of preeclampsia and/or SGA.
The debate is still open whether UA is a simple marker of disease or has a causal role in the development of preeclampsia and/or retarded fetal growth. Although the cause of hyperuricemia in preeclampsia has not definitively been elucidated, current evidence suggests that decreased renal clearance is probably the most important mechanism. However, the increase in UA levels is too large to be attributed solely to the reduction of glomerular filtration rate; thus, there must also be decreased secretion or increased reabsorption. This phenomenon appears to be analogous to the decrease in urate clearance produced by the infusion of vasoconstrictors, such as norepinephrine, 22 and to the increase of blood UA level and diminution in its clearance observed in glomerulonephritis. 23 According to these considerations, UA could be an early marker of preeclampsia. Other than reduced renal clearance, there may occur increased placental production of UA secondary to placental ischemia and increased tropho- Dependent variables was birth weight centile; independent variables were as follows: age, gestation wk, serum creatinine, UA (current and first-trimester levels), hemoglobin and platelet levels, office and ambulatory systolic and diastolic BPs. UA indicates uric acid; BP, blood pressure. blast shedding, leading to further purine availability for breakdown. Fetuses exposed to hypoxia (eg, secondary to decreased placental perfusion) have been shown to have increased serum levels of purine metabolites. 24 In preeclampsia, therefore, it is conceivable that these metabolites can cross into the maternal circulation to be degraded by maternal xanthine oxidase. These latter mechanisms might explain the relationship between raised UA levels and fetal growth retardation. An active role for UA in the development of preeclampsia has been proposed: studies in animals have suggested that UA may play a more active part in the development of hypertension in preeclampsia and perhaps later in life. 25, 26 UA has been shown to induce endothelial dysfunction in humans 27, 28 and, recently, to be able to induce human trophoblast production of interleukin 1␤ by activating the Nod-like receptor Nalp 3, thus stimulating the expression of inflammasome components. 29 Finally, regarding BP parameters, the findings of our study show that ambulatory BP monitoring derived measures are better predictors of preeclampsia and (to a lesser extent) SGA, with respect to office BP, probably because of the high prevalence of white-coat hypertension in the pregnant population 30 ; however, only 24-hour average diastolic BP was significantly associated with SGA and birth weight centile and showed a borderline significant association with preeclampsia.
Perspectives
In conclusion, we believe the findings of our study show that, in women with suspected hypertension in pregnancy, serum UA Ͼ309 mol/L can accurately predict the later development of preeclampsia and, more so, an increment Ͼ113 mol/L from first-trimester levels. We provide threshold values that might prove useful in clinical practice, although, of course, further studies are necessary.
